Chronic Kidney Disease (CKD) & Related Comorbid Conditions Archives - Page 2 of 3 - NephU

+

Help Us Enhance Your NephU Experience

Help Us Enhance Your NephU Experience

User experience form

Email Address*(Required)

What is Your Specialty?*(Required)

Select all that apply (Select at least one)*

What are your goals for visiting NephU?(Required)

Learn about IgAN MOD and disease progression

Join the NephU community

Access additional IgAN resources

Select all that apply (Select at least one)*

How would you like to hear from us?(Required)

Biweekly Email Newsletters

Schedule a Meeting with a Medical Science Liaison

Learn About Upcoming Live/Virtual Events

Agree(Required)

By providing your name, email address, and other information, you are giving Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and companies working with OPDC permission to send you information from NephU. OPDC will not sell or transfer your name, address, or email address. You agree that should you use any material provided through NephU, you will attribute the source of that information to “NephU sponsored by Otsuka Pharmaceutical Development & Commercialization, Inc.” For additional information, please read our Privacy Policy. By submitting your information, you agree to the terms provided above, and the terms provided in our Terms of Use and our Privacy Policy.

*Required Field

Name

This field is for validation purposes and should be left unchanged.

Major Depressive Disorder In Chronic Kidney Disease

Live Event October 19 from 6:00 pm to 8:00 pm PDT

Major Depressive Disorder affects more than 260 million people worldwide1. The reported prevalence of depression in patients with Chronic Kidney Disease (CKD) ranges from 20-65%2. This presentation provides an overview… Read More

Living Kidney Donation: One Solution for Patients with End-Stage Kidney Disease

Live Event October 3 from 6:30 pm to 9:00 pm PDT

This presentation discusses the challenges patients with end-stage kidney disease face and explores the barriers and benefits of living kidney donation. Read More

Major Depressive Disorder (MDD) In Chronic Kidney Disease (CKD)

Live Event August 8 from 6:30 pm to 8:00 pm MDT

Major depressive disorder (MDD) affects more than 260 million people worldwide. The reported prevalence of depression in patients with chronic kidney disease (CKD) ranges from 20-65%. This presentation provides an… Read More

Living Kidney Donation: One Solution For Patients With End-Stage Kidney Disease

Live Event July 17 from 6:30 pm to 9:00 pm PDT

This presentation discusses the challenges patients with end-stage kidney disease face and explores the barriers and benefits of living kidney donation. Read More

Debunking 5 Common Myths Around Peritoneal Dialysis

Live Event June 15 from 6:00 pm to 8:00 pm PDT

This presentation reviews and counters common perceived barriers to utilizing peritoneal dialysis in various populations. Read More

Major Depressive Disorder (MDD) In Chronic Kidney Disease (CKD)

Live Event May 18 from 6:30 pm to 9:00 pm PDT

Major depressive disorder (MDD) affects more than 260 million people worldwide. The reported prevalence of depression in patients with chronic kidney disease (CKD) ranges from 20-65%. This presentation provides an… Read More

Major Depressive Disorder (MDD) In Chronic Kidney Disease (CKD)

Live Event April 6 from 6:00 pm to 8:00 pm EDT

Major depressive disorder (MDD) affects more than 260 million people worldwide. The reported prevalence of depression in patients with chronic kidney disease (CKD) ranges from 20-65%. This presentation provides an… Read More

Major Depressive Disorder (MDD) In Chronic Kidney Disease (CKD)

Live Event March 30 from 6:00 pm to 8:00 pm MDT

Major depressive disorder (MDD) affects more than 260 million people worldwide. The reported prevalence of depression in patients with chronic kidney disease (CKD) ranges from 20-65%. This presentation provides an… Read More

Major Depressive Disorder (MDD) In Chronic Kidney Disease (CKD)

Live Event November 17 from 6:30 pm to 8:30 pm PST

This presentation provides an overview of both MDD and CKD and discusses their overlap of symptomology. Read More

Test Event #3

Webinar October 10 from 2:30 pm to 3:00 pm EDT

NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the Kidney Health Community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.

May 2020 MRC2.CORP.X.04767

August 2024 US.CORP.X.24.00265

©2024 Otsuka Pharmaceutical Development & Commercialization, Inc. All rights reserved.